BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 6137381)

  • 1. Haemodynamic consequences of intrinsic sympathomimetic activity and cardioselectivity in beta-blocker therapy for hypertension.
    Man in 't Veld AJ; Schalekamp MA
    Eur Heart J; 1983 Jul; 4 Suppl D():31-41. PubMed ID: 6137381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ; Schalekamp MA
    Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central haemodynamic effects of beta blockers in hypertension. A comparison between atenolol, metoprolol, timolol, penbutolol, alprenolol pindolol and bunitrolol.
    Lund-Johansen P
    Eur Heart J; 1983 Jul; 4 Suppl D():1-12. PubMed ID: 6137366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta blockers with intrinsic sympathomimetic activity.
    White WB
    Am Fam Physician; 1985 Jan; 31(1):115-8. PubMed ID: 2857059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.
    Svendsen TL
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S21-5. PubMed ID: 6188916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodynamic long-term effects of beta-receptor-blocking agents in hypertension: a comparison between alprenolol, atenolol, metoprolol and timolol.
    Lund-Johansen P; Ohm OJ
    Clin Sci Mol Med Suppl; 1976 Dec; 3():481S-483S. PubMed ID: 15759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do beta-blockers really increase peripheral vascular resistance? Review of the literature and new observations under basal conditions.
    Man in't Veld AJ; Van den Meiracker AH; Schalekamp MA
    Am J Hypertens; 1988 Jan; 1(1):91-6. PubMed ID: 2897200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and long-term haemodynamic effects of propranolol and indenolol in hypertension.
    Malacco E; Mailland F; Bosisio E; Meroni R; Dagani R; Renesto E; Bevilacqua M
    Eur J Clin Pharmacol; 1986; 30(2):157-60. PubMed ID: 3709639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential benefit of combination therapy with diuretics and beta blockers having intrinsic sympathomimetic activity.
    Weinberger MH
    Eur Heart J; 1990 Jun; 11(6):560-5. PubMed ID: 1972064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of beta blockers on vascular resistance in systemic hypertension.
    Man in 't Veld AJ
    Am J Cardiol; 1987 May; 59(13):21F-25F. PubMed ID: 2883873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
    Roberts DH; Tsao Y; Grimmer SF; Winstanley PA; Orme ML; Breckenridge AM
    Br J Clin Pharmacol; 1987 Aug; 24(2):163-72. PubMed ID: 2887190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta blockers in hypertension.
    Thadani U
    Am J Cardiol; 1983 Nov; 52(9):10D-15D. PubMed ID: 6139008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
    Lund-Johansen P
    Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and chronic hemodynamic effects of drugs with different actions on adrenergic receptors: a comparison between alpha blockers and different types of beta blockers with and without vasodilating effect.
    Lund-Johansen P; Omvik P
    Cardiovasc Drugs Ther; 1991 Jun; 5(3):605-15. PubMed ID: 1678963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodynamic long-term effects of metoprolol at rest and during exercise in essential hypertension.
    Lund-Johansen P; Ohm OJ
    Br J Clin Pharmacol; 1977 Apr; 4(2):147-51. PubMed ID: 861129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic effects of new beta-blockers with vasodilatory properties in essential hypertension.
    Tsukiyama H; Otsuka K; Horii M
    Drugs; 1988; 36 Suppl 6():48-54. PubMed ID: 2908304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
    van den Meiracker AH; Man in't Veld AJ; Boomsma F; Fischberg DJ; Molinoff PB; Schalekamp MA
    Circulation; 1989 Oct; 80(4):903-14. PubMed ID: 2571431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodynamic effects of beta-receptor blockade during acute administration and chronic treatment.
    Jensen HA
    Acta Med Scand Suppl; 1982; 665():79-81. PubMed ID: 6130678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous beta-blockade in coronary heart disease: is cardioselectivity or intrinsic sympathomimetic activity hemodynamically useful?
    Taylor SH; Silke B; Lee PS
    N Engl J Med; 1982 Mar; 306(11):631-5. PubMed ID: 6120457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of intrinsic sympathomimetic activity for beta blockers.
    Jaillon P
    Am J Cardiol; 1990 Sep; 66(9):21C-23C. PubMed ID: 1977302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.